leukemia

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

Learn about new developments in next generation molecular sequencing tests at the DUHS Clinical Labs' Clinical Molecular Diagnostics Laboratory.

A study co-led by DCI researcher Harry P. Erba, MD, PhD, demonstrated that quizartinib plus chemo doubled AML survival time.

As Duke celebrates its 50th anniversary of cancer discovery and care, researchers and providers envision the future.

Leukemia survivor and Duke Heart NP Dayana Ramos will hold a Be The Match drive at Duke University Hospital on June 24

Kris Wood, PhD, and colleagues have discovered a potential new drug therapy for leukemia that's preparing to enter clinical trials.

As Duke celebrates its 50th anniversary of transforming cancer discovery and care, researchers and providers look toward the next half century. 

The Eighth Annual DCI Scientific Retreat was one for the books.

Join Team DCI and "Light the Night" Oct. 21 to support blood cancer awareness and research. The virtual program includes a ceremony, lantern raising, social celebration & fireworks.

This OHE event, taped Aug. 19, focused on leukemia, lymphoma, and multiple myeloma: risk factors, symptoms, diagnosis,  latest treatments.

The new Duke Blood Cancer Center opens up the opportunity to transition some cancer treatments from the inpatient to the outpatient setting and the infusion room is open every day.

A study co-led at Duke SoM & Mass. General Hospital demonstrates benefits of early palliative care for high-risk leukemia patients. Results published in JAMA. Thomas LeBlanc, MD, is co-lead author.

After losing her younger brother to cancer, Ross Harris says getting involved with Duke Cancer Institute gave her power over the disease.

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

Flags were lowered to half-staff today across Duke for Neil Spector, MD, physician-scientist, mentor, advocate, friend, husband, and father who passed away on June 14.

Harry Erba, MD, PhD, David Rizzieri, MD, and Thomas LeBlanc, MD, discuss the benefits of therapy for the great majority of older acute myeloid leukemia patients.

Hematologist-oncologist Suzanne Kirby, MD, PhD, will lead the way for Duke Cancer Institute’s Wake County teams as an honorary captain at Light the Night.

Duke Hematologic Malignancies & Cellular Therapy will host its second annual benefit Cornhole Games on Thursday, Oct. 3.

DCI blood cancer researchers shared new scientific discoveries and treatments in lymphomas, leukemias, and multiple myeloma at OncLive summit.